| CAS ID: | 116094-23-6 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Protein based biotech |
| Natural Product: | No |
| Other Names: | INA-X14 | INS NOVORAPID | INSULIN X14 | INSULIN ASPART | NOVOLOG | INSULIN ASPART RECOMBINANT | NOVOLOG INNOLET | NOVOLOG PENFILL | NOVOLOG FLEXTOUCH | FIASP FLEXTOUCH | FIASP | NOVOLOG FLEXPEN | B28-ASP-INSULIN |
| Analysis: | N/A |
Trial Record 1
| ClinicalTrial ID | NCT02496780 | Disease | Cystic fibrosis |
| Phase | Phase 2,Phase 3 | Status | Recruiting |
| First Received | July 14, 2015 | Last Verified | March 25, 2019 |
| Sponsor | University of Minnesota - Clinical and Translational Science Institute | ||
Trial Record 2
| ClinicalTrial ID | NCT01149005 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Unknown |
| First Received | June 23, 2010 | Last Verified | June 23, 2010 |
| Sponsor | Hadassah Medical Organization | ||
Trial Record 3
| ClinicalTrial ID | NCT00072904 | Disease | Cystic fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | November 14, 2003 | Last Verified | February 28, 2012 |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | ||
| PubChem: | 126843213 |
| ChEMBL: | CHEMBL1201496 |